Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a radiation oncology company that manufactures and sells precise, leading-edge treatment solutions that revolve around the patient. Accuray's innovative technologies – the CyberKnife and TomoTherapy Systems – set the standard of care with the aim of helping patients live longer, better lives. For more information, please visit
Sunnyvale, US
Size (employees)
1,010 (est)
Accuray is headquartered in Sunnyvale, US

Accuray Office Locations

Accuray has offices in Sunnyvale, New York, Chiyoda, Morges and in 4 other locations
Sunnyvale, US
New York, US
Chiyoda, JP
Morges, CH
Madison, US
Shanghai, CN
Chengdu, CN

Accuray Metrics

Accuray Summary

Market capitalization

$448 M

Closing share price

Accuray's current market capitalization is $448 M.

Accuray Financials

Accuray's revenue is $399 M in FY, 2016 which is a 5.0% increase from the previous period.
FY, 2016FY, 2015FY, 2014


$399 M$380 M$369 M

Revenue growth, %


Gross profit

$159 M$145 M$143 M

Operating income

$-4.87 M$-19.2 M$-18.1 M

Operating expense total

$164 M$165 M$161 M

Net Income

$-25.5 M$-40.2 M$-35.4 M

Operating cash flow

$40.2 M$-12.8 M$19 M

Accuray Market Value History

Market Position – Health, medical devices, Manufacturing & Industrial, therapy services

Accuray Online Presence

Accuray News

Accuray Company Life

You may also be interested in